Robert Guy brought this wrongful discharge action after being fired from his supervisory position at Travenol’s North Carolina drug manufacturing plant, allegedly for refusing to falsify certain production and control records. Travenol denied those allegations in its answer and responded that, under North Carolina’s doctrine of employment at will, an employer may fire an employee for virtually any reason. The district court granted defendant’s motion to dismiss for failure to state a claim under North Carolina law. We think the district court properly interpreted North Carolina law, and we affirm its judgment.
I.
In his complaint, Guy alleged that Travenol employees were falsifying certain records “pertaining to the quality and quantity” of pharmaceuticals that drug manufacturers are required to keep under the Food and Drug Administration regulations. 21 C.F.R. § 211.180-198. Falsification of these records may violate the Food, Drug, and Cosmetic Act. 21 U.S.C. § 301, et seq. (1972). When Guy allegedly notified his supervisors that they were violating federal law, he was told to cooperate. When he allegedly refused to falsify the records to exclude wasted and defective drugs, he was fired. Travenol denies these allegations. Because the complaint was dismissed under Fed.R.Civ.P. 12(b)(6) for failure to state a claim, however, these alleged facts must be accepted as true. In his prayer for relief, plaintiff claims compensatory damages of $12,138 and punitive damages of $1,000,000.
II.
Federal courts must consider the availability of any wrongful discharge suit in North Carolina against the backdrop of North Carolina’s manifest commitment to the doctrine of employment at will. The North Carolina Supreme Court first recognized the doctrine in the 19th century and has reaffirmed its contemporary vitality. The state Supreme Court has applied it even in cases where the employer had indisputably offered permanent employment. Its cases admit but two exceptions, neither of which is applicable here.
In its pristine form, the doctrine of employment at will permits an employee to be discharged for almost any reason. As a matter of tort law, the doctrine precludes an action for wrongful discharge.
Tuttle v. Kernersville Lumber Co.,
The doctrine of employment at will apparently began in
Edwards v. Seaboard R.R. Co.,
where the court stated that an employee and employer were free “to sever
*913
their relationship at will, for their own convenience.”
Even where an employer agreed that an employee would “have a permanent job as long as (his) work was satisfactory,” the court again found the employment to be at will.
Tuttle v. Kernersville Lumber Co.,
The North Carolina Supreme Court summed up the doctrine when it said “a contract of employment, even though it expressly refers to the employment as ‘a regular, permanent job,’ is terminable at the will of either party irrespective of the quality of performance by the other party.”
Still v. Lance,
The North Carolina Court of Appeals has built upon the state Supreme Court’s strong support for the concept. In one case, the employee handbook provided that laid-off employees would be hired back according to seniority. When the employer laid off some employees with the possibility of recall within the year, it subsequently hired independent contractors and temporary help rather than rehire the idled employees. The court held that the laid-off workers had no cause of action because their employment was terminable at will.
Smith v. Monsanto Co.,
In
Bennett v. Eastern Rebuilders, Inc.,
As these cases reveal, the at will doctrine commands long and continued support in the North Carolina courts even in what may appear unusual and extenuating circumstances. The courts of North Carolina have recognized that every adverse employment decision presents a potentially litigable conflict of fact and perception, that the judicial resources of North Carolina should not generally be expended on such matters, and that the freedom of employers to dismiss employees perceived as unreliable or incompetent should not be lightly circumscribed.
It is, of course, immaterial whether a federal court sitting in diversity subscribes to North Carolina’s choice in this perennial area of state law controversy. The North Carolina Supreme Court has recognized but two exceptions to the doctrine: an employee has a wrongful discharge suit only when he obtains an employment contract of fixed duration or gives some extra consideration, such as a change of residence or the dismissal of a personal injury claim, in return for permanent employment. Still,
III.
Confronted with this body of precedent, Guy relies upon the recent case of
Sides v. Duke Hospital,
which he believes creates a public policy exception to the at will doctrine. In
Sides,
the North Carolina Court of Appeals held that an employer cannot fire an employee for refusing to commit perjury.
In
Sides,
a nurse alleged that she was fired because she refused to perjure herself both as a deponent and a witness in a medical malpractice case. The court’s opinion emphasized the need to prevent perjury and preserve judicial integrity. As the court noted, perjury is “an affront to the integrity of our judicial system, an impediment to the constitutional mandate of the courts to administer justice fairly, and a violation of the- right that all litigants in this State have to have their cases tried upon honest evidence fully given.”
Sides,
Despite some language dealing with the general need to uphold the law and support public policy, the court’s holding was very specific: “no employer in this State, notwithstanding that an employment is at will, has the right to discharge an employee ... because he refuses to testify untruthfully or incompletely in a court case.”
Sides,
The
Sides
case is limited, however, by more than its holding and its language. Three subsequent appellate cases reaffirm the narrow scope of that decision. In
Walker v. Westinghouse Elec. Co.,
The court characterized
Sides
as granting a cause of action to employees “on the grounds that the public policy requiring truthfulness before our courts outweighed the employer’s freedom to discharge employees at will.”
Walker,
In
Trought v. Richardson,
The North Carolina Court of Appeals continued to limit the new exception in
Hogan v. Forsyth Country Club Co.,
In sum, the Sides opinion and the holdings of three subsequent appellate cases reveal that, instead of seriously eroding the at will doctrine, Sides was intended to be a limited perjury exception. At this point, the law of North Carolina is well-established. An employer may terminate any employee for any reason unless the employee has a specific duration contract, gave some additional consideration for permanent employment, or lost his job for refusing to give perjured testimony. Because his complaint does not come within any of these exceptions, Guy has failed to state a cause of action under state law.
IV.
Having failed to allege a cause of action under state law, Guy offers a more expansive argument. According to Guy, this court should create a cause of action because, if employees can be fired for complying with the Food, Drug, and Cosmetic Act, 21 U.S.C. § 301, et seq., they will be more willing to falsify records, which would impair the Food and Drug Administration’s enforcement of the Act. Whatever the appeal of this argument, Guy is presenting it to the wrong forum. A federal court sitting in diversity simply cannot compel a state to provide a cause of action in tort to supplement enforcement of a federal statute.
Despite Guy’s warnings to the contrary, creating a state recovery in tort is not the only way to protect the public against the sale of impure drugs. Congress has enacted a detailed statutory scheme to enforce the Act’s prohibition of the sale of adulterated drugs. Under this scheme, drug companies must manufacture their products in accordance with the FDA’s regulations on “current good manufacturing practices.” 21 U.S.C. §§ 331, 351(a)(2)(B) (1972). In addition to regulating the actual manufacture of drugs, these regulations require drug companies to keep accurate production and control records. 21 C.F.R. § 211.180-198. To ensure that drug companies comply with these regulations, the Act provides the FDA with broad statutory authority to inspect a manufacturer’s plant and examine any “records, files, papers, processes, controls and facilities.” 21 U.S.C. § 374(a)(1) (Supp.1986).
*916 If the agency discovers a violation, the Act provides numerous remedies. For example, the FDA may seize the adulterated drugs. 21 U.S.C. § 334(a) (Supp.1986). The agency may also seek an injunction against any manufacturing practice that violates the Act. 21 U.S.C. § 332(a) (1972). Most importantly, producers of adulterated drugs are subject to possible criminal sanctions of up to three years imprisonment and a maximum fine of $10,000. 21 U.S.C. § 333(b) (1972).
In sum, the Food, Drug, and Cosmetic Act establishes a complex enforcement scheme. Under this scheme, Travenol is subject to unannounced agency inspections. The FDA may seize any impure or adulterated drugs, and may seek to enjoin any company practice in violation of the statute. Any Travenol employees who violate the statute by falsifying required records are subject to criminal sanctions.
According to Guy, this federal enforcement scheme is incomplete unless he is allowed to bring a wrongful discharge suit. Because, as we have noted, North Carolina has been reluctant to recognize such an action, Guy is essentially arguing that the state should be compelled to supplement the Act’s enforcement scheme by providing a wrongful discharge action. North Carolina, however, has no obligation to use its tort law system to supplement the enforcement of a federal statute. As the Supreme Court has noted, “the State’s interest in fashioning its own rule of tort law is paramount to any discernible federal interest....”
Martinez v. California,
Congress itself has declined to pass an anti-retaliation statute to protect employees who refuse to violate the Food, Drug, and Cosmetic Act. Congress was apparently aware of the potential risks faced by employees who refuse to cooperate with an employer’s violation of a statute. Several statutory schemes provide that, if an employee is fired for instituting or assisting an agency investigation of a suspected statutory violation, the employee must be reinstated with back pay. See, e.g., Federal Water Pollution Control Act, 33 U.S.C. § 1367 (1986); Federal Surface Mining Control and Reclaimation Act of 1977, 30 U.S.C. § 1293 (1986); Energy Reorganization Act of 1974, 42 U.S.C. § 5851.
Congress could have protected Guy by establishing a similar procedure by which drug company employees could notify the FDA of a violation without fear of retaliatory termination. If such a statute had been passed, Guy could have refused Travenol’s demand to violate the FDA regulations, reported the violation to the agency, and been protected from a retaliatory firing. Rather than provide this employee protection, Congress has decided to enforce the Food, Drug, and Cosmetic Act through a different statutory scheme. We are loathe to require the states to create a protective scheme in tort where Congress has declined to pass such legislation in furtherance of its own enactment.
The decision to create an additional measure of enforcement through a wrongful discharge action involves a choice between two competing state policies, a choice federal courts sitting in diversity cannot make. One policy, which has its academic champions, is the protection of employees against employer abuse. See Blades, Employment at Will vs. Individual Freedom: On Limiting the Abusive Exercise of Employer Power, 67 Colum.L.Rev. 1404 (1967); Summers, Individual Protection Against Dismissal: Time for a Statute, 62 Va.L.Rev. 481 (1976). Recognizing the claim here might indeed have salutary consequences. It might protect those employees who follow FDA regulations, prevent unscrupulous employers from forcing employees to choose between holding their job or following federal law, and prevent the sale of impure drugs.
For all these possible benefits, however, a wrongful discharge action may also have undesirable effects. There is a risk that *917 many employees who are properly terminated will try to claim the exception, particularly those in sensitive drug-related industries such as pharmacies, pharmaceutical companies, doctors’ offices, and hospitals. There is a danger that the always uncertain prospects of litigation will deter employers in these industries from legitimate personnel decisions, even with respect to those employees whose continued contact with drugs in the workplace poses a variety of public risks.
The balance between encouraging legitimate claims and discouraging spurious ones is for North Carolina to strike. So also is the balance between employee rights and employer perogatives. This is particularly true in tort and contract law, whose elements of recovery and damages lie at the heart of state, not federal, public policy. When confronted with a request to modify or create a state cause of action, a federal court must recall the Supreme Court’s admonition that “where in (diversity) cases one is barred from recovery in the state court, he should likewise be barred in the federal court.”
Woods v. Interstate Realty Co.,
The point is as simple as it is unavoidable: in diversity cases, when state law provides an answer, federal courts must abide by that law. North Carolina law does provide the answer in this case: outside of a few restricted limitations that do not apply, an employer may terminate an employee for any reason. Thus, Guy has no cause of action against Travenol. In applying state law, federal courts have always found the road straighter and the going smoother when, instead of blazing new paths, they restrict their travels to the pavement.
The judgment of the district court is
AFFIRMED.
Notes
Hogan
does offer some slight support for Guy’s position because it characterized
Sides
as creating a cause of action for employees who refuse "to perform an act prohibited by law.”
Hogan,
